Analyst Craig Bijou of Bank of America Securities reiterated a Hold rating on Merit Medical Systems, retaining the price target of $100.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Craig Bijou’s rating is based on the recent appointment of Martha Aronson as the new CEO of Merit Medical Systems, which is expected to alleviate investor concerns regarding leadership succession. Although this change is seen positively, Bijou anticipates that the company’s strategic direction will remain largely unchanged, focusing on its continued growth initiatives.
Despite a preliminary revenue beat in the second quarter, with expectations exceeding street forecasts, Bijou maintains a Hold rating due to limited potential for significant valuation expansion in the current market environment. Additionally, while there is an expectation of reduced tariff impacts, the overall financial outlook remains cautious, contributing to the neutral stance.
MMSI’s price has also changed slightly for the past six months – from $95.860 to $91.120, which is a -4.94% drop .